Market Pulse50Neutral

Hims & Hers Health, Inc.Opportunity Rank #41(HIMS) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$22.46

Last updated: Mar 24, 2026

Price vs Intrinsic Value

$22.46
Price
$60.51
Intrinsic Value
Undervalued by 169%MOS: $48.41

Fundamental Score

79/100
Bullish

Weighted across 6 signals

Narrative Score

72/100
Strong

No change vs previous

The intrinsic value of Hims & Hers Health, Inc. (HIMS) is estimated at $60.51 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $22.46, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.63% long-term growth rate and a 10.00% discount rate (calculated: 9.90%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Hims & Hers Health, Inc. (HIMS) is estimated at $60.51 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $22.46, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 14.63% long-term growth rate and a 10.00% discount rate (calculated: 9.90%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$60.51
169.41% upside
20% margin of safety: $48.41
Years: 10Growth Rate: 14.63%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
8.34%
Cost of Capital (estimated)10%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.

Fundamental Details

79/100
BullishWeighted across 6 signals
DCF Discount
169.4% discount to price
100
FCF Yield
10.8% trailing FCF yield
100
ROIC vs WACC
ROIC 8.3% vs WACC 10.0% (0.8x)
42
Net Debt / FCF
1.0x net debt to FCF
59
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
213.8% 5Y FCF CAGR
100
Strengths lead the score: DCF Discount, FCF Yield.

Narrative Details

72/100
Strong
Vs 6-Month Baseline:Above Avg (76th pct)Weighted across 6 recent drivers
Trend: Deteriorating downConfidence: 95%Updated: 1h ago
Sources: 218 (200 News · 18 Analyst)
Drivers(last 30 days)
142 news sentiment+1.7
24 regulatory scrutiny+0.4
3 analyst upgrades+0.2
29 legal risk+0.0
2 earnings beat-0.0
Analyst downgrades-0.0

Investment Coach

Updated 19h ago
BUYConfidence: 69%
Thesis
Hims & Hers Health, Inc. is significantly undervalued with an estimated fair value 176% above its current price, supported by strong fundamentals and a bullish score of 79. Despite trailing returns relative to its cost of capital, the company shows promising free cash flow growth and a supportive narrative score of 74.
Key Risk
The company's return on invested capital remains below its weighted average cost of capital, posing a risk to sustained profitability.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Track ROIC versus WACC spread for sustained improvement.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 73.87%5 Year CAGR (Adjusted): 255.07%

Free Cash Flow (in millions)

TTM2025202420232022202120202019
$534$526$304$100-$19-$29$2-$73

How Intrinziq Estimates Fair Value

Intrinziq estimates Hims & Hers Health, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Hims & Hers Health, Inc.Healthcare

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

Related Articles

Deep dives and valuation takes on HIMS.